In summary, this study demonstrates that the survival of ESCC patients can be predicted with a reasonable accuracy by using a simple discriminant function based on UBE2C and MGP gene expression and clinical stage. The gene discussed is UBE2C; the disease is esophageal squamous cell carcinoma.